GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sinew Pharma 6634.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

56.70

+2.16%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 47,000

FY2016FY2025

Net income

−TWD 123.7m

FY2016FY2025

Free cash flow

−TWD 97.2m

FY2016FY2025

Shareholders' equity

TWD 1.09bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 47,000——TWD 328,000TWD 6.2mTWD 462,000————
Gross profitTWD 37,000−TWD 30.3m−TWD 29.0mTWD 290,000TWD 5.1mTWD 324,000————
Research and developmentTWD 97.5mTWD 113.6mTWD 133.5mTWD 114.6mTWD 72.7mTWD 66.7mTWD 60.3mTWD 44.0mTWD 51.9mTWD 37.4m
Operating income−TWD 140.1m−TWD 168.9m−TWD 186.3m−TWD 148.4m−TWD 94.4m−TWD 84.1m−TWD 76.0m−TWD 75.9m−TWD 85.4m−TWD 67.9m
Net income−TWD 123.7m−TWD 150.4m−TWD 170.9m−TWD 140.2m−TWD 91.6m−TWD 82.0m−TWD 76.2m−TWD 74.5m−TWD 81.7m−TWD 67.2m
Diluted earnings per share-1.74-2.11-2.41-2.02-1.54-1.60-1.94-1.89-2.08-2.06

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.13bnTWD 1.23bnTWD 1.36bnTWD 1.49bnTWD 1.58bnTWD 453.2mTWD 420.8mTWD 252.3mTWD 322.5mTWD 391.2m
Cash and short-term investments—TWD 1.16bnTWD 1.28bnTWD 1.39bnTWD 1.48bnTWD 338.3mTWD 292.7mTWD 123.0mTWD 179.6mTWD 236.3m
Total liabilitiesTWD 36.4mTWD 28.9mTWD 39.7mTWD 28.7mTWD 16.0mTWD 17.4mTWD 252.0mTWD 12.1mTWD 8.5mTWD 7.1m
Debt—TWD 2.8mTWD 9.3mTWD 7.5mTWD 1.1mTWD 3.3mTWD 5.2m———
Shareholders' equityTWD 1.09bnTWD 1.20bnTWD 1.32bnTWD 1.46bnTWD 1.57bnTWD 435.8mTWD 168.8mTWD 240.2mTWD 314.0mTWD 384.1m
Shares outstanding71m71m71m70m59m51m39m39m39m33m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 95.3m−TWD 106.1m−TWD 118.0m−TWD 93.8m−TWD 57.3m−TWD 59.3m−TWD 58.7m−TWD 55.4m−TWD 58.7m−TWD 50.6m
Capital spending−TWD 1.9m−TWD 1.3m−TWD 7.5m−TWD 5.9m−TWD 5.9m−TWD 2.7m−TWD 6.7m−TWD 1.2m−TWD 242,000−TWD 734,000
Free cash flow−TWD 97.2m−TWD 107.4m−TWD 125.5m−TWD 99.6m−TWD 63.2m−TWD 62.0m−TWD 65.4m−TWD 56.6m−TWD 58.9m−TWD 51.4m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Revenue——————TWD 328,000TWD 3.1m
Gross profit−TWD 13.5m−TWD 15.1m−TWD 30.4m−TWD 15.0m——TWD 290,000TWD 2.5m
Operating income−TWD 74.3m−TWD 85.3m−TWD 83,518−TWD 113,355−TWD 72,898−TWD 41,735−TWD 139.9m−TWD 45.7m
Net income−TWD 65.4m−TWD 76.5m−TWD 73,875−TWD 104,604−TWD 66,317−TWD 39,181−TWD 140.1m−TWD 45.8m
Diluted earnings per share-0.92-1.07-0.00-0.00-0.00-0.00-2.02-0.77
Cash from operations−TWD 50.0m−TWD 46.0m−TWD 59.0m−TWD 63.0m———−TWD 28.0m
Capital spending——−TWD 3.0m————−TWD 2.0m
Free cash flow——−TWD 62.0m————−TWD 30.0m
Total assetsTWD 1.18bnTWD 1.23bnTWD 1.29bnTWD 1.36bnTWD 1.44bnTWD 1.49bn—TWD 1.58bn
Cash and short-term investmentsTWD 1.10bnTWD 1.16bnTWD 1.21bnTWD 1.28bnTWD 1.34bnTWD 1.39bn—TWD 1.48bn
DebtTWD 11.5mTWD 5.6mTWD 12.2mTWD 12.9mTWD 6.3mTWD 3.0m—TWD 1.1m
Shareholders' equityTWD 1.15bnTWD 1.20bnTWD 1.26bnTWD 1.32bnTWD 1.41bnTWD 1.46bn—TWD 1.57bn

Financial ratios

Data as of 25 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin78.7%——88.4%81.7%70.1%—
Operating margin-261889.4%——-42654.0%-1467.8%-17692.0%—
Net margin-263287.2%——-42737.8%-1470.1%-17751.3%—
Return on equity-11.3%-12.6%-12.9%-9.6%-5.8%-18.8%—
Return on assets-11.0%-12.3%-12.5%-9.4%-5.8%-18.1%—
Free cash flow yield-2.4%-2.6%-2.8%-2.3%-1.6%-2.0%—
Revenue growth———-94.7%1248.3%——
Earnings growth-17.7%-12.0%21.9%53.1%11.7%7.6%—
Current ratio42.27x43.46x36.81x60.56x99.36x22.71x—
Debt to equity—0.00x0.01x0.00x0.00x0.01x0.01x
Equity ratio96.8%97.6%97.1%98.1%99.0%96.2%—
Interest coverage-187.35x-362.21x-240.02x-508.75x-626.23x-298.31x—
R&D as a share of sales207391.5%——34944.5%1167.8%14438.3%—
Buybacks as a share of market value0.4%-0.6%-1.9%-16.9%-16.0%-30.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-47.7%-36.7%—
Operating income-1.9%10.7%11.2%
Net income-4.1%8.6%10.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-22.5-22.5-28.1-52.3-53.3-56.0-12.6-7.1-11.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.